 |
|
Simple eye scan opens window to multiple sclerosis
October 16, 2007Potential to track the disease at a fraction of the cost of current test
A five-minute eye exam might prove to be an inexpensive and effective way to gauge and track the debilitating neurological disease multiple sclerosis, potentially complementing costly magnetic resonance imaging to detect brain shrinkage - a characteristic of the disease's progression.
A Johns Hopkins-based study of a group of 40 multiple sclerosis (MS) patients used a process called optical coherence tomography (OCT) to scan the layers of nerve fibers of the retina in the back of the eye, which become the optic nerve. The process, which uses a desktop machine similar to a slit-lamp, is simple and painless. The retinal nerve fiber layer is the one part of the brain where nerve cells are not covered with the fat and protein sheathing called myelin, making this assessment specific for nerve damage as opposed to brain MRI changes, which reflect an array of different types of tissue processes in the brain.
Results of the scans were calibrated using accepted norms for retinal fiber thickness and then compared to an MRI of each of the patient's brains - also calibrated using accepted norms. Experimenters found a correlation coefficient of 0.46, after accounting for age differences. Correlation coefficients represent how closely two variables are related -- in this case MRI of the brain and OCT scans. Correlation coefficients range from -1 (a perfect opposing correlation) through 0 (no correlation) to +1 (a perfect positive correlation). In a subset of patients with relapsing remitting MS, the most common form of the disease, the correlation coefficient jumped to 0.69, suggesting an even stronger association between the retinal measurement and brain atrophy.
"This is an encouraging result," says Johns Hopkins neurologist Peter Calabresi, M.D., lead author of the study, which appears in the October 2007 issue of Neurology. "MRI is an imperfect tool that measures the result of many types of tissue loss rather than specifically nerve damage itself. With OCT we can see exactly how healthy these nerves are, potentially in advance of other symptoms."
In addition, says Calabresi, OCT scans take roughly one-tenth as long and cost one-tenth as much as the MRI, which means they are faster and cheaper to use in studies that track the effectiveness of new treatments for MS.
Approximately 400,000 people in the United States have MS, marked by an abnormal immune system that attacks and kills a person's own brain cells. As these neurons die, the volume of the brain decreases. MRI of the brain, which can measure total volume, has long been the primary tool used to monitor MS. But MRI, aside from being expensive and uncomfortable, is often misleading since brain inflammation - also a symptom of the disease - can skew brain volume readings. Also, the brain begins shrinking relatively late in the progression of the disease, so MRI isn't as good at detecting the disease in its early stages when treatments are most effective. OCT scans look directly at the thickness, and therefore health, of the optic nerve, which is affected early on in the disease, often before the patient suffers permanent brain damage.
Calabresi added that many of the disabilities suffered by MS patients - numbness, tingling, visual impairment, fatigue, weakness and bladder function disturbance - are the result of nerve cell degeneration, so a test that specifically measures nerve cell health is potentially the clearest picture of the status of the disease.
He cautions that optic nerve damage can point to a number of diseases and is not a unique diagnostic tool for MS. However, he says, it certainly sends up a flag suggesting that MS might be present. And since optic nerve damage is one of the first recognizable symptoms of MS, doctors have a chance to identify the disease potentially before the patient suffers the physical limitations generally associated with its advanced stages.
"Treatments for MS cannot reverse the damage but they can arrest it, so the earlier we get someone on medication the quicker we can stop the disease from causing more harm," says Calabresi. This tool may be useful as an outcome measure in MS clinical trials to assess the efficacy of neuroprotective drugs.
In the study, researchers recruited 40 patients from the Johns Hopkins MS clinic. Twenty had relapsing remitting MS, 15 had secondary progressive MS, and five had primary progressive MS. Researchers also recruited 15 healthy control patients free from ophthalmological or neurological disease as a comparison group.
Calabresi says his next step will be to look at changes in the fiber layer thickness in 100 patients over a period of three years.
Johns Hopkins Medical Institutions
Results of the scans were calibrated using accepted norms for retinal fiber thickness and then compared to an MRI of each of the patient's brains - also calibrated using accepted norms. Experimenters found a correlation coefficient of 0.46, after accounting for age differences. Correlation coefficients represent how closely two variables are related -- in this case MRI of the brain and OCT scans. Correlation coefficients range from -1 (a perfect opposing correlation) through 0 (no correlation) to +1 (a perfect positive correlation). In a subset of patients with relapsing remitting MS, the most common form of the disease, the correlation coefficient jumped to 0.69, suggesting an even stronger association between the retinal measurement and brain atrophy.
"This is an encouraging result," says Johns Hopkins neurologist Peter Calabresi, M.D., lead author of the study, which appears in the October 2007 issue of Neurology. "MRI is an imperfect tool that measures the result of many types of tissue loss rather than specifically nerve damage itself. With OCT we can see exactly how healthy these nerves are, potentially in advance of other symptoms."
In addition, says Calabresi, OCT scans take roughly one-tenth as long and cost one-tenth as much as the MRI, which means they are faster and cheaper to use in studies that track the effectiveness of new treatments for MS.
Approximately 400,000 people in the United States have MS, marked by an abnormal immune system that attacks and kills a person's own brain cells. As these neurons die, the volume of the brain decreases. MRI of the brain, which can measure total volume, has long been the primary tool used to monitor MS. But MRI, aside from being expensive and uncomfortable, is often misleading since brain inflammation - also a symptom of the disease - can skew brain volume readings. Also, the brain begins shrinking relatively late in the progression of the disease, so MRI isn't as good at detecting the disease in its early stages when treatments are most effective. OCT scans look directly at the thickness, and therefore health, of the optic nerve, which is affected early on in the disease, often before the patient suffers permanent brain damage.
Calabresi added that many of the disabilities suffered by MS patients - numbness, tingling, visual impairment, fatigue, weakness and bladder function disturbance - are the result of nerve cell degeneration, so a test that specifically measures nerve cell health is potentially the clearest picture of the status of the disease.
He cautions that optic nerve damage can point to a number of diseases and is not a unique diagnostic tool for MS. However, he says, it certainly sends up a flag suggesting that MS might be present. And since optic nerve damage is one of the first recognizable symptoms of MS, doctors have a chance to identify the disease potentially before the patient suffers the physical limitations generally associated with its advanced stages.
"Treatments for MS cannot reverse the damage but they can arrest it, so the earlier we get someone on medication the quicker we can stop the disease from causing more harm," says Calabresi. This tool may be useful as an outcome measure in MS clinical trials to assess the efficacy of neuroprotective drugs.
In the study, researchers recruited 40 patients from the Johns Hopkins MS clinic. Twenty had relapsing remitting MS, 15 had secondary progressive MS, and five had primary progressive MS. Researchers also recruited 15 healthy control patients free from ophthalmological or neurological disease as a comparison group.
Calabresi says his next step will be to look at changes in the fiber layer thickness in 100 patients over a period of three years.
Johns Hopkins Medical Institutions
Optic Nerve Current Events and Optic Nerve News RSSResearchers find new way to attack inflammation in Graves' eye disease
A small group of patients with severe Graves' eye disease experienced rapid improvement of their symptoms - and improved vision - following treatment with the drug rituximab.
Master regulator found for regenerating nerve fibers in live animals
Researchers at Children's Hospital Boston report that an enzyme known as Mst3b, previously identified in their lab, is essential for regenerating damaged axons (nerve fibers) in a live animal model, in both the peripheral and central nervous systems.
First in New York: Bionic technology aims to give sight to woman blinded beginning at age 13
A 50-year-old New York woman who was diagnosed with a progressive blinding disease at age 13 was implanted with an experimental electronic eye implant that has partially restored her vision.
Elevated arginase levels contribute to vascular eye disease such as diabetic retinopathy
Elevated levels of the enzyme arginase contribute to vascular eye damage and Medical College of Georgia researchers say therapies to normalize its levels could halt progression of potentially blinding diseases such as diabetic retinopathy.
Unlikely genetic suspect implicated in common brain defect
A genetic search that wound its way from patients to mouse models and back to patients has uncovered an unlikely gene critically involved in a common birth defect which causes mental retardation, motor delays and sometimes autism, providing a new mechanism and potentially improving treatment for the disorder.
Study provides documentation that tumor 'stem-like cells' exist in benign tumors
Cancer stem-like cells have been implicated in the genesis of a variety of malignant cancers. Research scientists at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute have isolated stem-like cells in benign (pituitary) tumors and used these "mother" cells to generate new tumors in laboratory mice.
Clue to normal-tension glaucoma; herpes infection and corneal transplants
The July issue of Ophthalmology, the journal of the American Academy of Ophthalmology, includes two studies that may influence clinical treatment of serious eye conditions.
Cell's split personality is a major discovery into neurological diseases
Researchers at the Université de Montreal (UdeM) and the Montreal Neurological Institute (MNI), McGill University have discovered that cells which normally support nerve cell (neuron) survival also play an active and major role in the death of neurons in the eye.
Genetic sleuth solves glaucoma mystery
Dr. Michael Walter is one good gumshoe. The University of Alberta medical geneticist has cracked the case of WDR36, a gene linked to glaucoma.
MRI scans can predict effects of MS flare-ups on optic nerve
One of the most pernicious aspects of multiple sclerosis (MS) - its sheer unpredictability - may finally be starting to yield to advanced medical imaging techniques.
More Optic Nerve Current Events and Optic Nerve News Articles
 |
Optic Nerve: Perceptual Art of the 1960s by Joe Houston (Author), Dave Hickey (Introduction) The abstract art movement Op art came to international attention in the mid-1960s, an era of global social and technological change. The movement, which placed emphasis on viewer perception by exploring optical effects in painting, sculpture and light installation, quickly gained in popularity but met with considerable criticism. This important book, published to accompany the first major Op art exhibition by an American museum in twenty-five years, examines the development of the movement, its cultural context and its widespread impact on advertising, fashion and film-making. Featuring visually stunning works by such key figures as Josef Albers, Bridget Riley and Victor Vasarely, Optic Nerve offers a timely reappraisal of this highly influential movement. The ... |
 |
Optic Nerve Beta Sunglasses, Shiny Black by Optic Nerve Optic Nerve is Colorado to the Core. A high performance mid price sunglass for the Outdoor Advernture Enthusiast |
 |
32 Stories: The Complete Optic Nerve Mini-Comics by Adrian Tomine (Author), Adrian Tomine (Illustrator) In 1991, Adrian Tomine self-published the first issue of Optic Nerve. Consisting of three xeroxed sheets of paper, and with a print run of twenty-five, it was a less-than-auspicious, largely unnoticed debut. In the following three years, though, Optic Nerve developed at a startlingly rapid pace: the artwork and writing evolved with each story, production quality improved, page counts increased, and by issue seven, sales had reached 6,000. In 1994, Drawn & Quarterly took over the publishing duties of Optic Nerve, and the original seven issues sold out and were left out of print. 32 stories presents these rare, early editions, collected for the first time in a single volume. |
 |
Optic Nerve Response PM Sunglasses, Shiny Black by Optic Nerve Optic Nerve is Colorado to the Core. A high performance mid price sunglass for the Outdoor Advernture Enthusiast |
 |
Optic Nerve Fusebox Sunglasses,Shiny Fade Pink by Optic Nerve Optic Nerve is a high performance mid price sunglass for the Outdoor Adventure Enthusiast |
 |
Optic Nerve: 30 Postcards by Adrian Tomine (Illustrator) This remarkably illustrated collection of postcards features the best of Tomine's distinctive, critically acclaimed Optic Nerve comic book series, as well as selections from his work for magazines such as The New Yorker, album covers, and more. Share these 30 different postcards or keep them all to yourself. |
 |
Optic Nerve Revolt Sunglasses, Shiny Black by Optic Nerve Optic Nerve is Colorado to the Core. A high performance mid price sunglass for the Outdoor Advernture Enthusiast |
|
Lotta Nerve by The Optic Nerve Entire recorded output by New York City's amazing Garage band from the 80's and still active today. All songs here are gorgeous originals, with a folk/rock sound that shimmers and sparkles. The songwriting is excellent across the board; with comparisons to Gene Clark, Emitt Rhodes and Michael Brown being easy to see. Certain songs jump out at the listener: “Like To Get To Know Her” with its breathtaking Byrds/Searchers-like harmonies, “Take Me” with the clever psychish opening, and “I See The Truth” with its hooks and guitar lines. | |
 |
Vertigo (Live Show Mix) Optic Nerve (Primary Contributor) |
 |
Sleepwalk: and Other Stories by Adrian Tomine (Author) Collecting the first four issues of Adrian Tomine's acclaimed comic series optic nerve, this book offers sixteen concise, haunting tales of modern life. The characters here appear to be well-adjusted on the surface, but Tomine takes us deeper into their lives, subtly examining their struggle to connect with friends and lovers. |
| © 2009 BrightSurf.com |